References
- Adamovics JA. Chromatographic analysis of pharmaceuticals. Marcel Dekker, New York, Basel, Hong Kong 1997; 11–17
- Alvarez-Román R, Barré G, Guy RH, Fessi H. Biodegradable polymer nanocapsules containing a sunscreen agent: Preparation and photoprotection. Eur J Pharm Biopharm 2001; 52: 191–5
- Aulton ME. Aulton's pharmaceutics: The design and manufacture of medicines. Churchill Livingstone Elsevier, Philadelphia 2007; 176–7
- Carstensen JT. Advanced pharmaceutical solids. Marcel Dekker, pp., New York, Basel 2001, 302, 311
- Davis WL, Gloor WT. Batch production of pharmaceutical granulations in a fluidized bed I: Effects of process variables on physical properties of final granulation. J Pharm Sci 1971; 60(12): 1869–74
- Diffey BL, Robson J. A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum. J Soc Cosmet Chem 1989; 40: 127–33
- Gaspar LR, Maia Campos PMBG. Evaluation of the photostability of different UV filter combinations in a sunscreen. Int J Pharm 2006; 30: 123–8
- Gaspar LR, Maia Campos PMBG. Photostability and efficacy studies of topical formulations containing UV filters combination and vitamins A, C and E. Int J Pharm 2007; 343: 181–9
- Huong SP, Andrieu V, Reynier JP, Rocher E, Fourneron JD. The photoisomerization of the sunscreen ethylhexyl p-methoxy cinnamate and its influence on the sun protection factor. J Photochem Photobiol A: Chem 2007; 186: 65–70
- Iannuccelli V, Sala N, Tursilli R, Coppi G, Scalia S. Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability. Eur J Pharm Biopharm 2006; 63: 140–5
- Janjura NR, Mogensen B, Anderson AM, Peterson JH, Henriksen M, Shakkebaek NE, Wulf HC. Systemic absorption of the sunscreens benzophenone-3, octyl methoxycinnamate, and 3-(4-methylbenzylidene) camphor after whole body topical application and reproductive hormone levels in humans. J Invest Dermatol 2004; 123: 57–61
- Kullavanijaya P, Lim HW. Photoprotection. J Am Acad Dermatol 2005; 52: 937–58
- Mckinlay AF, Diffey BL. A reference action spectrum for ultraviolet induced erythema in human skin. CIE J 1987; 6: 17–22
- Nour SA, El Gazayerly ON, Abdel Malak NS. 2006. A pharmaceutical study on novel cosmeceutical preparations containing antioxidants, Dissertation, Cairo University, Egypt
- Pattanaargson S, Limphong P. Stability of octyl methoxycinnamate and identification of its photo-degradation product. J Cosmet Sci 2001; 23: 153–60
- Pattanaargson S, Munhapol T, Hirunsupachot P, Luangthongaram P. Photoisomerization of the octyl methoxycinnamate. J Photochem Photobiol A: Chem 2004; 161: 269–74
- Perguini P, Simeoni S, Scalia S, Genta I, Modena T, Conti B, Pavanetto F. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate. Int J Pharm 2002; 246: 37–45
- Ramadan A, El Massik M, El Khordagui L, Daabis N, Hammouda Y. Surface treatment: A potential approach for enhancement of solid-state photostability. Int J Pharm 2006; 307: 141–9
- Scalia S, Tursilli R, Sala N, Iannucelli V. Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-β-cyclodextrin. Int J Pharm 2006; 320: 79–85
- Sinko PJ. Martin's physical pharmacy and pharmaceutical sciences. Lippincott Williams and Wilkins, Philadelphia 2006; 558
- Tursilli R, Casolari A, Iannuccelli V, Scalia S. Enhancement of melatonin photostability by encapsulation in lipospheres. J Pharm Biomed Anal 2006; 40: 910–14
- Tursilli R, Piel G, Delattre L, Scalia S. Solid lipid microparticles containing the sunscreen agent octyl-dimethylaminobenzoate: Effect of the vehicle. Eur J Pharm Biopharm 2007; 66: 483–7
- Wells J. Pharmaceutical preformulation. The physicochemical properties of drug substances. Ellis Horwood Limited, UK 1988; 209–210
- Westesen K, Siekmann B. Microencapsulation, Bonita S, ed. 1996, Methods and industrial applications. New York, Basel: Marcel Dekker, pp. 214–7, 232
- Wissing SA, Müller RH. The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. Int J Pharm 2002; 242: 373–5